Professor levent t rkeri from istanbul tr was the
This presentation is the property of its rightful owner.
Sponsored Links
1 / 3

Professor Levent Türkeri from Istanbul (TR) was the PowerPoint PPT Presentation


  • 47 Views
  • Uploaded on
  • Presentation posted in: General

Professor Levent Türkeri from Istanbul (TR) was the winner of the urology challenge sessions which were chaired by that expert of audience participation and founder of this forum Prof. F. Debruyne (BE); in a very close run contest where all of the lectures given were

Download Presentation

Professor Levent Türkeri from Istanbul (TR) was the

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Professor levent t rkeri from istanbul tr was the

Professor Levent Türkeri from Istanbul (TR) was the

winner of the urology challenge sessions which were

chaired by that expert of audience participation and

founder of this forum Prof. F. Debruyne (BE); in a very close run contest where all of the lectures given were

of very high quality. In three state of the art lectures

Prof. Türkeri comprehensively reviewed

the problems which we face with tumour

heterogeneity in the management of urothelial cancer:

“Clearly we need improved markers for tumour

behaviour, in order to most effectively individualise our

therapy for patients in the future”.

He emphasised the potential importance of a tertiary

Gleason pattern in the management of prostate cancer

and provide a well reasoned argument for the need for

a paradigm shift in our treatment of naïve metastatic

prostate cancer. He suggested a potential early role for

chemotherapy in appropriately selected hormone

resistant patients.


  • Login